Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 3
2005 3
2006 9
2007 4
2008 8
2009 11
2010 13
2011 5
2012 4
2013 3
2018 4
2019 7
2020 16
2021 12
2022 8
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal Muscle Biopsies Reveal Inter- and Intra-Subject Variability in Cancer Cachexia: Paving the Way for Biopsy-Guided Tailored Treatment.
Filis P, Tzavellas NP, Stagikas D, Zachariou C, Lekkas P, Kosmas D, Dounousi E, Sarmas I, Ntzani E, Mauri D, Korompilias A, Simos YV, Tsamis KI, Peschos D. Filis P, et al. Among authors: mauri d. Cancers (Basel). 2024 Mar 6;16(5):1075. doi: 10.3390/cancers16051075. Cancers (Basel). 2024. PMID: 38473431 Free PMC article.
TAMs and PD-1 Networking in Gastric Cancer: A Review of the Literature.
Yerolatsite M, Torounidou N, Gogadis A, Kapoulitsa F, Ntellas P, Lampri E, Tolia M, Batistatou A, Katsanos K, Mauri D. Yerolatsite M, et al. Among authors: mauri d. Cancers (Basel). 2023 Dec 30;16(1):196. doi: 10.3390/cancers16010196. Cancers (Basel). 2023. PMID: 38201623 Free PMC article. Review.
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Dimitrakopoulos FI, Goussia A, Koliou GA, Dadouli K, Batistatou A, Kourea HP, Bobos M, Arapantoni-Dadioti P, Tzaida O, Koletsa T, Chrisafi S, Sotiropoulou M, Papoudou-Bai A, Nicolaou I, Charchanti A, Mauri D, Aravantinos G, Binas I, Res E, Psyrri A, Pectasides D, Bafaloukos D, Koumarianou A, Bompolaki I, Rigakos G, Karanikiotis C, Koutras A, Zagouri F, Gogas H, Fountzilas G. Dimitrakopoulos FI, et al. Among authors: mauri d. Breast. 2024 Feb;73:103668. doi: 10.1016/j.breast.2023.103668. Epub 2023 Dec 25. Breast. 2024. PMID: 38176305 Free PMC article.
Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer.
Fountzilas E, Papadopoulou K, Chatzikonstantinou T, Karakatsoulis G, Constantoulakis P, Tsantikidi A, Tsaousis G, Karageorgopoulou S, Koumarianou A, Mauri D, Ntavatzikos A, Saridaki Z, Petrakis G, Fostira F, Fountzilas G, Liontos M. Fountzilas E, et al. Among authors: mauri d. Cancers (Basel). 2023 Nov 22;15(23):5525. doi: 10.3390/cancers15235525. Cancers (Basel). 2023. PMID: 38067228 Free PMC article.
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.
Alexandraki A, Papageorgiou E, Zacharia M, Keramida K, Papakonstantinou A, Cipolla CM, Tsekoura D, Naka K, Mazzocco K, Mauri D, Tsiknakis M, Manikis GC, Marias K, Marcou Y, Kakouri E, Konstantinou I, Daniel M, Galazi M, Kampouroglou E, Ribnikar D, Brown C, Karanasiou G, Antoniades A, Fotiadis D, Filippatos G, Constantinidou A. Alexandraki A, et al. Among authors: mauri d. Cancers (Basel). 2023 Jun 22;15(13):3290. doi: 10.3390/cancers15133290. Cancers (Basel). 2023. PMID: 37444400 Free PMC article. Review.
Circulating Tumor DNA in the Management of Early-Stage Breast Cancer.
Vlataki K, Antonouli S, Kalyvioti C, Lampri E, Kamina S, Mauri D, Harissis HV, Magklara A. Vlataki K, et al. Among authors: mauri d. Cells. 2023 Jun 7;12(12):1573. doi: 10.3390/cells12121573. Cells. 2023. PMID: 37371043 Free PMC article. Review.
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Linardou H, Lampaki S, Koliou GA, Vozikis A, Boutis A, Nikolaidi A, Kontogiorgos I, Papakotoulas P, Christopoulou A, Spyratos D, Bafaloukos D, Psyrri A, Grivas A, Koumarianou A, Tsiakitzis K, Mauri D, Rigakos G, Aravantinos G, Papantoniou P, Oikonomopoulos G, Fountzilas E, Koufaki MI, Kaparelou M, Liolis E, Mountzios G, Kosmidis P, Fountzilas G, Samantas E. Linardou H, et al. Among authors: mauri d. Anticancer Res. 2023 Jun;43(6):2799-2812. doi: 10.21873/anticanres.16449. Anticancer Res. 2023. PMID: 37247889
118 results